BioTek Germany Certified in Accordance with EN ISO 13485
News Dec 17, 2012
BioTek Germany was recently awarded certification in accordance with EN ISO 13485:2003.
This certification confirms that administration, sales and distribution, warehouse management, service/repair, and installation at the subsidiary all fulfill the quality management system requirements for medical devices as set out in this standard.
BioTek's manufacturing facility and headquarters in Winooski, Vermont is similarly certified in accordance with EN ISO 13485.
BioTek's EN ISO 13485 certification guarantees that all of its products and services satisfy the requirements, and comply with the currently valid legislation, relating to medical devices.
Thomas Brunner, Managing Director of BioTek Instruments, GmbH, explains, "Medical technology products must fulfill the most rigorous safety criteria. The fact that our quality management system complies with EN ISO 13485 - which goes above and beyond the requirements of ISO 9001 - proves that we are committed to ensuring quality and efficiency. It also provides our customers with documentary evidence that our development processes and methods meet the highest standards in the field of medical technology."
U.S. Study of Dapivirine Ring in Lactating Women Finds Little Drug Gets Into Breast MilkNews
The antiretroviral drug dapivirine that is released from an experimental vaginal ring to protect against HIV is absorbed in very low concentrations into breastmilk.READ MORE
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease TreatmentNews
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).READ MORE
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Target Engagement in Biology and Drug Discovery
Feb 19 - Feb 23, 2018